[go: up one dir, main page]

RU2004122915A - Ингибиторы продуцирования / секреции b-амилоидного белка - Google Patents

Ингибиторы продуцирования / секреции b-амилоидного белка Download PDF

Info

Publication number
RU2004122915A
RU2004122915A RU2004122915/04A RU2004122915A RU2004122915A RU 2004122915 A RU2004122915 A RU 2004122915A RU 2004122915/04 A RU2004122915/04 A RU 2004122915/04A RU 2004122915 A RU2004122915 A RU 2004122915A RU 2004122915 A RU2004122915 A RU 2004122915A
Authority
RU
Russia
Prior art keywords
group
alkyl
groups
amino
alkylamino
Prior art date
Application number
RU2004122915/04A
Other languages
English (en)
Other versions
RU2304140C2 (ru
Inventor
Таканори ЯСУКОУТИ (JP)
Таканори ЯСУКОУТИ
Масаюки ИТО (JP)
Масаюки ИТО
Хидеки КУБОТА (JP)
Хидеки КУБОТА
Сатору МИЯУТИ (JP)
Сатору МИЯУТИ
Масанори САИТО (JP)
Масанори САИТО
Original Assignee
Дайити Фармасьютикал Ко., Лтд. (JP)
Дайити Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайити Фармасьютикал Ко., Лтд. (JP), Дайити Фармасьютикал Ко., Лтд. filed Critical Дайити Фармасьютикал Ко., Лтд. (JP)
Publication of RU2004122915A publication Critical patent/RU2004122915A/ru
Application granted granted Critical
Publication of RU2304140C2 publication Critical patent/RU2304140C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/76—Sulfur atoms attached to a second hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (16)

Измененная формула изобретения, предложенная заявителем для рассмотрения
1. Соединение, представленное следующей формулой (3):
Figure 00000001
(где R15 представляет гетероциклическую группу, которая может иметь заместитель, R16 представляет циклическую углеводородную группу, которая может иметь заместитель, или гетероциклическую группу, которая может иметь заместитель, R17 представляет циклическую углеводородную группу, которая может иметь заместитель, или гетероциклическую группу, которая может иметь заместитель, R18 представляет атом водорода или С1-6алкильную группу, а Х представляет –S-, -SO- или –SO2-); или N-оксид или S-оксид данного соединения; их соль; или сольват описанного выше соединения.
2. Соединение по п.1, где Х представляет –SO- или –SO2-; или N-оксид или S-оксид данного соединения; их соль; или сольват описанного выше соединения.
3. Соединение по п.1, где Х представляет –SO2-; или N-оксид или S-оксид данного соединения; их соль; или сольват описанного выше соединения.
4. Соединение по любому из пп.1-3, где гетероциклическая группа, представленная R15, R16 или R17, является 3-7-членной насыщенной или 4-7-членной ненасыщенной моноциклической гетероциклической группой, имеющей 1-4 атома, выбранных из атома азота, атома кислорода и атома серы, или 7-14-членной полициклической гетероциклической группой, имеющей 1-4 атома, выбранных из атома азота, атома кислорода и атома серы; или N-оксид или S-оксид данного соединения; их соль; или сольват описанного выше соединения.
5. Соединение по любому из пп.1-3, где циклическая углеводородная группа, представленная R16 или R17, является циклоалкильной группой имеющей 3-7 атомов углерода, циклоалкенильной группой, имеющей 4-7 атомов углерода, моноциклической или полициклической ароматической углеводородной группой, имеющей 6-14 атомов углерода, спироуглеводородной группой, имеющей 7-11 атомов углерода, циклической углеводородной группой с поперечными (мостиковыми) связями, имеющей 7-10 атомов углерода, или конденсированной углеводородной группой, имеющей 8-14 атомов углерода; или N-оксид или S-оксид данного соединения; их соль; или сольват описанного выше соединения.
6. Соединение по любому из пп.1-3, где заместителем для циклической углеводородной группы или гетероциклической группы, представленной R15, R16 или R17, является группа –Q201-Q202-Q203-Q204–Q205-Q206-Q207, где Q201 представляет простую связь, алкильную группу, имеющую 1-6 атомов углерода, алкенильную группу, имеющую 2-6 атомов углерода или гетероциклическую группу; Q202 представляет простую связь, -О-, -NH-, -CH=N-, -С(алкил)=N-, -N(алкил)- или –S-; Q203 представляет простую связь, -СО-, -CS-, -SO-, -SO2- или –CONH-; Q204 представляет простую связь, алкильную группу, имеющую 1-6 атомов углерода, алкенильную группу, имеющую 2-6 атомов углерода, циклоалкильную группу, циклоалкенильную группу, ароматическую углеводородную группу или гетероциклическую группу; Q205 представляет простую связь, -NH- или –N(алкил)-; Q206 представляет простую связь, -О-, -СО-, -CS-, -SO2-, -SO- или –S-; и Q207 представляет атом водорода, атом галогена, гидроксигруппу, оксогруппу,
С1-6алкильную группу, С2-6алкенильную группу,
С3-8циклоалкильную группу, С1-6алкоксигруппу,
С2-6алкенилоксигруппу, азидогруппу, цианогруппу, аминогруппу,
С1-6алкиламиногруппу, ди(С1-6алкил)аминогруппу,
С2-6алканоиламиногруппу, ди(С2-6алканоил)аминогруппу,
карбоксиаминогруппу, С1-6алкоксикарбониламиногруппу,
ди(С1-6алкокси)карбониламиногруппу, гетероциклическую группу,
ароматическую углеводородную группу, циклоалкенильную группу,
гетероциклилоксигруппу или ароматический углеводородоксигруппу,
(где алкильная группа, имеющая 1-6 атомов углерода, алкенильная группа, имеющая 2-6 атомов углерода, циклоалкильная группа, циклоалкенильная группа, гетероциклическая группа, гетероциклическая оксигруппа, ароматическая углеводородная группа или ароматический углеводородоксигруппа может быть замещена 1-3 заместителями, выбранными из атомов галогена,
С1-6алкильных групп, С1-6алкоксигрупп, С2-6алкенильных групп,
карбоксиамино-С1-6алкильных групп,
С1-6алкоксикарбониламино-С1-6алкильных групп,
формильной группы, С2-6алканоильных групп, оксогруппы,
нитрогруппы, цианогруппы, азидогруппы, амидиногруппы,
С2-6алкенилоксигрупп, гидроксигруппы, карбоксильной группы,
С7-16аралкильных групп, тиоксогруппы, С2-7алканоильных групп,
С2-7тиоалканоильных групп, тиоформильной группы, аминогруппы,
С1-6алкиламиногрупп, ди(С1-6алкил)аминогрупп,
С1-6алкоксикарбонильных групп, карбамоильной группы,
С1-6алкилкарбамоильных групп, ди(С1-6алкил)карбамоильных групп,
тиокарбамоильной группы, С1-6алкилтиокарбамоильных групп,
ди(С1-6алкил)тиокарбамоильных групп,
С1-6алкоксикарбамоиламиногрупп,
С1-6алкоксикарбамоил(С1-6алкил)аминогрупп,
С2-7алканоиламиногрупп, С2-7алканоил(С1-6алкил)аминогрупп,
тио-С2-7алканоиламиногрупп, тио-С2-7алканоил(С1-6алкил)аминогрупп,
формиламиногруппы, формил(С1-6алкил)аминогрупп,
тиоформиламиногруппы, тиоформил(С1-6алкил)аминогрупп,
С2-7алканоилоксигрупп, формилоксигруппы,
С1-6алкоксикарбонилоксигрупп, карбамоилоксигруппы,
С1-6алкилкарбамоилоксигрупп, ди(С1-6алкил)карбамоилоксигрупп,
аминокарбониламиногруппы, (С1-6алкил)аминокарбониламиногрупп,
ди(С1-6алкил)аминокарбониламиногрупп,
аминокарбонил(С1-6алкил)аминогрупп,
(С1-6алкил)аминокарбонил(С1-6алкил)аминогрупп,
ди(С1-6алкил)аминокарбонил(С1-6алкил)аминогрупп,
меркаптогруппы, С1-6алкилтиогрупп, С1-6алкилсульфинильных групп,
С1-6алкилсульфонильных групп, аминосульфонильной группы,
С1-6алкиламиносульфонильных групп,
ди(С1-6алкил)аминосульфонильных групп,
С1-6алкилсульфониламиногрупп,
С1-6алкилсульфонил(С1-6алкил)аминогрупп,
аминосульфониламиногруппы, С1-6алкиламиносульфониламиногрупп,
ди(С1-6алкил)аминосульфониламиногрупп,
аминосульфонил(С1-6алкил)аминогрупп,
С1-6алкиламиносульфонил(С1-6алкил)аминогрупп и
ди(С1-6алкил)аминосульфонил(С1-6алкил)аминогрупп; или
N-оксид или S-оксид данного соединения; их соль; или
сольват описанного выше соединения.
7. Соединение по любому из пп.1-3, где R16 и R17, каждый, представляет моноциклическую или полициклическую ароматическую углеводородную группу, имеющую 6-14 атомов углерода, или гетероциклическую группу (где эта углеводородная группа или гетероциклическая группа может иметь 1-3 заместителя, выбранных из атомов галогена, С1-6алкильных групп,
С1-6алкоксигрупп, С2-6алкенильных групп, формильной группы,
С2-6алканоильных групп, карбоксильной группы,
карбоксиамино-С1-6алкильных групп,
С1-6алкоксикарбониламино-С1-6алкильных групп,
оксогруппы, нитрогруппы, цианогруппы, амидиногруппы,
С2-7алкенилоксигрупп, гидроксигруппы, тиоксогруппы, аминогруппы,
С1-6алкиламиногрупп, ди(С1-6алкил)аминогрупп,
С1-6алкоксикарбонильных групп, карбамоильной группы,
С1-6алкилкарбамоильных групп, ди(С1-6алкил)карбамоильных групп,
тиокарбамоильной группы, С1-6алкилтиокарбамоильных групп,
ди(С1-6алкил)тиокарбамоильных групп, меркаптогруппы,
С1-6алкилтиогрупп, С1-6алкилсульфинильных групп и
С1-6алкилсульфонильных групп);
и R15 представляет гетероциклическую группу (где гетероциклическая группа может быть замещена атомом галогена,
С1-6алкильной группой, С1-6алкоксигруппой,
С2-6алкенильной группой, С2-6алкенилоксигруппой, гидроксигруппой,
карбоксильной группой, карбокси-С1-6алкильной группой,
С1-6алкоксикарбонил-С1-6алкильной группой,
С1-6алкоксикарбонил-С2-6алкенильной группой,
гидроксил-С1-6алкильной группой,
С6-14ароматический углеводородсульфонил-С1-6алкильной группой,
гетероциклил-С1-6алкиламиногруппой, гетероциклической группой,
гетероциклил-С1-6алкильной группой,
С6-14ароматической углеводородной группой,
С6-14ароматический углеводород-С1-6алкильной группой,
С6-14ароматический углеводород-тио-С1-6алкильной группой,
азидо-(С1-6алкил)группой, амино-С1-6алкильной группой,
С1-6алкиламино-С1-6алкильной группой,
ди-С1-6алкиламино-С1-6алкильной группой,
гидроксил-С1-6алкиламино-С1-8алкильной группой,
С1-6алкокси-С1-6алкиламино-С1-6алкильной группой,
(гидрокси-С1-6алкил)(С1-6алкокси-С1-6алкил)амино-С1-6алкильной группой,
С2-6алканоиламино-С1-6алкильной группой,
С6-14ароматический углеводород-сульфониламино-С1-6алкильной группой,
С1-6алкоксикарбониламино-С1-6алкильной группой,
карбамоиламино-С1-6алкильной группой,
N-алкилкарбамоиламино-С1-6алкильной группой,
N,N-диалкилкарбамоиламино-С1-6алкильной группой,
аминосульфониламино-С1-6алкильной группой,
N-алкилсульфониламино-С1-6алкильной группой,
N,N-диалкилсульфониламино-С1-6алкильной группой,
С6-14ароматический углеводород-С1-6алкиламиногруппой,
гетероциклил-С1-6алкиламиногруппой,
карбамоилокси-С1-6алкильной группой,
N-алкилкарбамоилокси-С1-6алкильной группой,
N,N-диалкилкарбамоилокси-С1-6алкильной группой,
С6-14ароматический углеводород-С1-6алкилкарбамоилокси-С1-6алкильной группой,
С1-6алкоксикарбонилокси-С1-6алкильной группой,
С6-14ароматический углеводород-оксикарбонилокси-С1-6алкильной группой,
С6-14ароматический углеводород-сульфониламино-С1-6алканоиламино-С1-6алкильной группой,
С1-6алкоксикарбониламино-С1-6алкиламиногруппой,
амино-С1-6алкиламиногруппой, С1-6алкиламино-С1-6алкиламиногруппой,
ди(С1-6алкил)амино-С1-6алкиламиногруппой,
карбоксиамино-С1-6алкильной группой,
С1-6алкоксикарбониламино-С1-6алкильной группой,
С1-6алкилсульфониламино-С1-6алкильной группой,
амино-С1-6алкилкарбониламино-С1-6алкильной группой,
N-С1-6алкиламино-С1-6алкилкарбониламино-С1-6алкильной группой,
N,N-ди-С1-6алкиламино-С1-6алкилкарбониламино-С1-6алкильной группой,
гетероциклилкарбонильной группой,
гетероциклилкарбониламиногруппой,
С6-14ароматический углеводородкарбонильной группой,
С6-14ароматической карбониламиногруппой,
гетероциклил-С1-6алкилкарбониламино-С1-6алкильной группой,
гетероциклил-С2-6алкенилкарбониламино-С1-6алкильной группой,
С6-14ароматический углеводородалкенилкарбониламино-С1-6алкильной группой,
С6-14ароматический углеводородкарбониламино-С1-6алкильной группой,
гетероциклилкарбониламино-С1-6алкильной группой,
С1-6алкоксиоксалиламино-С1-6алкильной группой,
карбамоильной группой, N-С1-6алкилкарбамоильной группой,
N,N-ди-С1-6алкилкарбамоильной группой,
С1-6алкил-С3-8циклоалкилкарбамоильной группой,
С3-8циклоалкил-С1-6алкилкарбамоильной группой,
гетероциклилкарбамоильной группой,
С1-6ароматической карбамоильной группой,
гетероциклилкарбонилгидразонометильной группой,
С6-14ароматический углеводородкарбонилгидразонометильной группой,
С1-6алкилтио-С1-6алкилкарбамоильной группой,
С1-6алкилсульфинил-С1-6алкилкарбамоильной группой,
С1-6алкилсульфонил-С1-6алкилкарбамоильной группой,
гидроксиаминокарбонильной группой,
гидразинокарбонильной группой или
N-С1-6алкилгидразинокарбонильной группой,
тиоформиламино-С6-14ароматический углеводородтиокарбониламино-С1-6алкильной группой
тиоформил(С1-6алкил)амино-С6-14ароматический углеводородтиокарбониламино-С1-6алкильной группой,
формиламино-С6-14ароматический углеводородкарбониламино-С1-6алкильной группой,
формил-С1-6алкиламино-С6-14ароматический углеводородкарбониламино-С1-6алкильной группой,
С1-6алканоилгетероциклкарбониламино-С1-6алкильной группой,
ди(С2-6алканоил)амино(С1-6алкил)группой,
ди(С1-6алкоксикарбонил)амино-С1-6алкильной группой,
С1-6алкилгетероциклкарбонильной группой,
С3-7циклоалкил-С1-6алкиламинокарбонильной группой,
С1-6алкоксиаминокарбонильной группой,
(гидрокси)(С1-6алкил)аминокарбонильной группой,
(С1-6алкокси)(С1-6алкил)аминокарбонильной группой,
N’-С1-6алкилгидразинокарбонильной группой,
N’,N’-ди-С1-6алкилгидразинокарбонильной группой,
N,N’-ди-С1-6алкилгидразинокарбонильной группой,
N,N’,N’-три-С1-6алкилгидразинокарбонильной группой,
N’-(гетероциклкарбонил)гидразинокарбонильной группой,
формильной группой, гидроксилиминогруппой,
С1-6алкоксииминогруппой,
бис(С1-6алкокси-С1-6алкил)амино-С1-6алкильной группой,
гидрокси-С1-6алкилгетероциклической группой,
С1-6алкокси-С1-6алкилгетероциклической группой,
С1-6алкоксикарбониламино-С1-6алкилгетероциклической группой,
амино-С1-6алкилгетероциклической группой,
N-С1-6алкиламино-С1-6алкилгетероциклической группой,
N,N-ди-С1-6алкиламино-С1-6алкилгетероциклической группой,
гидроксигетероциклической группой,
С1-6алкоксигетероциклической группой,
карбокси-С2-5алкенильной группой или
оксогруппой,
(где вышеуказанная С6-14ароматическая углеводородная группа или гетероциклическая группа может быть замещена атомом галогена, С1-6алкильной группой, С1-6алкоксигруппой,
С2-6алкенильной группой, формильной группой,
С2-6алканоильной группой, карбоксильной группой,
карбоксиамино-С1-6алкильной группой,
С1-6алкоксикарбониламино-С1-6алкильной группой, оксогруппой,
нитрогруппой, цианогруппой, амидиногруппой,
С2-6алкенилоксигруппой, гидроксигруппой, тиоксогруппой,
аминогруппой, С1-6алкиламиногруппой, ди-С1-6алкиламиногруппой,
амино-С1-6алкильной группой, С1-6алкоксикарбонильной группой,
карбамоильной группой, С1-6алкилкарбамоильной группой,
ди-С1-6алкилкарбамоильной группой, тиокарбамоильной группой,
С1-6алкилтиокарбамоильной группой,
ди(С1-6алкил)тиокарбамоильной группой,
С2-7алканоиламиногруппой, С2-7алканоил(С1-6алкил)аминогруппой,
тио(С2-7алканоил)аминогруппой,
тио(С2-7алканоил)(С1-6алкил)аминогруппой,
формиламиногруппой, формил(С1-6алкил)аминогруппой,
тиоформиламиногруппой, тиоформил(С1-6алкил)аминогруппой,
С2-7алканоилоксигруппой, формилоксигруппой, меркаптогруппой,
С1-6алкилтиогруппой, С1-6алкилсульфинильной группой,
С1-6алкилсульфонильной группой, аминосульфонильной группой,
С1-6алкиламиносульфонильной группой,
ди(С1-6алкил)аминосульфонильной группой,
С1-6алкилсульфониламиногруппой или
С1-6алкилсульфонил(С1-6алкил)аминогруппой); или
N-оксид или S-оксид данного соединения; их соль; или
сольват описанного выше соединения.
8. Лекарственное средство, содержащее, в качестве активного ингредиента, соединение по любому из пп.1-7 или N-оксид или S-оксид данного соединения, их соль или сольват описанного выше соединения.
9. Лекарственное средство по п.8, которое применяют для предупреждения или лечения заболевания, являющегося результатом аномального продуцирования или секреции β-амилоида.
10. Лекарственное средство по п.8, которое применяют для предупреждения или лечения болезни Альцгеймера или синдрома Дауна.
11. Фармацевтическая композиция, содержащая соединение по любому из пп.1-7 или N-оксид или S-оксид данного соединения, их соль или сольват описанного выше соединения, и фармацевтически приемлемый носитель.
12. Применение соединения по любому из пп.1-7 или N-оксида или S-оксида данного соединения, их соли или сольвата описанного выше соединения, для изготовления лекарственного средства.
13. Применение по п.12, где лекарственное средство применяют для предупреждения или лечения заболевания, являющегося результатом аномального продуцирования или секреции β-амилоидного белка.
14. Применение по п.12, где лекарственное средство применяют для предупреждения или лечения болезни Альцгеймера или синдрома Дауна.
15. Способ лечения заболевания, являющегося результатом аномального продуцирования или секреции β-амилоида, включающий введение эффективного количества соединения по любому из пп.1-7 или N-оксида или S-оксида данного соединения, их соли или сольвата описанного выше соединения.
16. Способ по п.15, где заболевание, являющееся результатом аномального продуцирования или секреции β-амилоидного белка, представляет собой болезнь Альцгеймера или синдром Дауна.
RU2004122915/04A 2001-12-27 2002-12-27 ИНГИБИТОРЫ ПРОДУЦИРОВАНИЯ / СЕКРЕЦИИ β-АМИЛОИДНОГО БЕЛКА RU2304140C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001395701 2001-12-27
JP2001-395701 2001-12-27

Publications (2)

Publication Number Publication Date
RU2004122915A true RU2004122915A (ru) 2005-04-10
RU2304140C2 RU2304140C2 (ru) 2007-08-10

Family

ID=19189019

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004122915/04A RU2304140C2 (ru) 2001-12-27 2002-12-27 ИНГИБИТОРЫ ПРОДУЦИРОВАНИЯ / СЕКРЕЦИИ β-АМИЛОИДНОГО БЕЛКА

Country Status (10)

Country Link
US (2) US7399775B2 (ru)
EP (1) EP1466898A4 (ru)
JP (1) JP4329905B2 (ru)
KR (1) KR100927304B1 (ru)
CN (1) CN100562516C (ru)
AU (1) AU2002367147A1 (ru)
CA (1) CA2471943C (ru)
RU (1) RU2304140C2 (ru)
TW (1) TWI330176B (ru)
WO (1) WO2003055850A1 (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108591D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0108592D0 (en) 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0120347D0 (en) 2001-08-21 2001-10-17 Merck Sharp & Dohme Therapeutic agents
WO2003055850A1 (en) * 2001-12-27 2003-07-10 Daiichi Pharmaceutical Co., Ltd. β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223038D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
JP4818114B2 (ja) 2003-05-16 2011-11-16 メルク シャープ エンド ドーム リミテッド γ−セクレターゼ阻害剤としてのシクロヘキシルスルホン類
KR20060066057A (ko) * 2003-06-30 2006-06-15 다이이찌 세이야꾸 가부시기가이샤 복소환 메틸 설폰 유도체
ME01059B (me) 2003-12-23 2012-10-20 Janssen Sciences Ireland Uc Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata
ZA200708531B (en) * 2005-04-08 2009-02-25 Daiichi Sankyo Co Ltd Pyridylmethylsulfone derivative
RU2404968C2 (ru) * 2005-04-08 2010-11-27 Дайити Санкио Компани, Лимитед Пиридилдиметилсульфоновое производное
JP2008115166A (ja) * 2006-10-10 2008-05-22 Daiichi Sankyo Co Ltd ピリジルフェニルメチルスルホン誘導体
TW200920362A (en) * 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
JP5816079B2 (ja) * 2008-04-23 2015-11-17 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ノッチスペアリングガンマセクレターゼ阻害剤としてのシクロブチルスルホン
EP2390248A1 (en) * 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
JP2013526597A (ja) * 2010-05-24 2013-06-24 ファエス・ファルマ・ソシエダッド・アノニマ アミロイド病変の治療および予防のためのフルフェノキシン誘導体
WO2012007836A1 (en) 2010-07-16 2012-01-19 Purdue Pharma .Lp. Pyridine compounds as sodium channel blockers
WO2012141228A1 (ja) * 2011-04-11 2012-10-18 株式会社ファルマエイト 新規ピラゾール誘導体
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
CN102850246B (zh) * 2012-07-10 2015-04-22 江西理工大学 一种苯胺类衍生物引入巯基的方法
CN103958480B (zh) 2012-09-04 2016-04-06 上海恒瑞医药有限公司 咪唑啉类衍生物、其制备方法及其在医药上的应用
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
EP3092221B1 (en) * 2014-01-06 2018-10-17 Bristol-Myers Squibb Company Heterocyclic sulfones as ror-gamma modulators
CN106132931B (zh) * 2014-01-06 2019-08-02 百时美施贵宝公司 碳环砜RORγ调节剂
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
JP7595854B2 (ja) * 2020-05-25 2024-12-09 地方独立行政法人大阪産業技術研究所 ［６，６］メタノフラーレン誘導体の製造方法
CN114249754B (zh) * 2021-12-15 2022-11-25 大连理工大学 基于内过氧结构的分子氧输送剂及应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849423A (en) * 1971-03-22 1974-11-19 Lilly Co Eli 3-benzylpyridines
US4055652A (en) * 1975-07-07 1977-10-25 Syntex (U.S.A.) Inc. 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof
ZA765075B (en) * 1975-09-25 1977-08-31 American Cyanamid Co Hypolipemic compounds and method of treatment
US4116665A (en) 1976-04-02 1978-09-26 Eli Lilly And Company Method of regulating the growth of aquatic weeds with pyridine derivatives
FR2375228A1 (fr) * 1976-12-23 1978-07-21 Parcor Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants
DE2724684A1 (de) * 1977-06-01 1978-12-14 Basf Ag Triazolsubstituierte schwefelverbindungen
DE2735314A1 (de) 1977-08-05 1979-02-22 Basf Ag Alpha-azolylsulfide und deren derivate
US4675316A (en) 1978-03-10 1987-06-23 Rohm And Haas Company Substituted azoylmethylarylsulfides and derivatives and pesticidal use thereof
DE2821829A1 (de) * 1978-05-19 1979-11-22 Basf Ag Mittel zur regulierung des pflanzenwachstums
ZA794030B (en) * 1978-08-08 1980-07-30 Sterling Drug Inc Aryl sulfinic acid derivatives of aliphatic,aromatic or heterocyclic compounds
US4257954A (en) 1978-08-08 1981-03-24 Sterling Drug Inc. Novel compounds, processes and marking systems
DE2855661A1 (de) * 1978-12-22 1980-07-03 Bayer Ag Arylsubstituierte methylen-1,3-diazaheterocyclen
US4379921A (en) * 1980-08-21 1983-04-12 Sumitomo Chemical Company, Limited Production of triazolylvinyl ketones
FR2509725A1 (fr) * 1981-07-15 1983-01-21 Choay Sa (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant
EP0117485A3 (de) * 1983-02-28 1985-01-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyridin-, Pyrazin- und Pyrimidinderivate und deren Verwendung als fungizide Wirkstoffe
DE3406908A1 (de) * 1984-02-25 1985-09-05 Hoechst Ag, 6230 Frankfurt Neue triazolylalkylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenbehandlungsmittel
JPS6239563A (ja) * 1985-08-13 1987-02-20 Hokko Chem Ind Co Ltd β−ニトロフエネチル誘導体および農園芸用殺菌剤
US5104882A (en) * 1987-11-25 1992-04-14 Merck Frosst Canada, Inc. Diarylstrylquinoline diacids and pharmaceutical compositions thereof
US5359078A (en) 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
DE4215437A1 (de) * 1992-05-11 1993-11-18 Paul Prof Dr Messinger Darstellung von Alkylacylaten mit ß-ständigen elektronenziehenden Resten im Alkylteil
JPH0625168A (ja) * 1992-07-10 1994-02-01 Nippon Bayeragrochem Kk 殺菌性ベンジルピリジン類
JPH0656780A (ja) * 1992-08-01 1994-03-01 Nippon Bayeragrochem Kk 殺菌性α−置換ベンジルピリジン類
DE19521355A1 (de) 1995-06-12 1996-12-19 Hoechst Schering Agrevo Gmbh Sulfonamide, Verfahren zu deren Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
JPH0995444A (ja) * 1995-10-02 1997-04-08 Teijin Ltd アミロイド蛋白凝集阻害剤
HU225960B1 (en) * 1997-02-27 2008-01-28 Takeda Pharmaceutical Amine compounds, their production and use
US6586475B1 (en) * 1998-11-20 2003-07-01 Takeda Chemical Industries, Ltd. β-amyloid protein production/secretion inhibitors
NZ514453A (en) 1999-02-26 2003-04-29 Merck & Co Inc Novel sulfonamide compounds and uses thereof
MXPA02002319A (es) * 1999-09-04 2002-07-30 Astrazeneca Ab Derivados 2-hidroxi-2-metil-3,3,3-trifluoropropanamida con n-fenilo susbtituido que elevan la actividad de la deshidrogenasa de piruvato.
MXPA02001813A (es) * 1999-09-13 2004-03-19 Bristol Myers Squibb Pharma Co Hidroxialcanoilaminolactamas y estructuras relacionas como inhibidores de la produccion de la proteina abeta.
JP2003523345A (ja) * 2000-02-17 2003-08-05 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Ａβタンパク質産生の阻害剤としてのスクシノイルアミノ炭素環および複素環
AU4086101A (en) 2000-03-20 2001-10-03 Merck Sharp & Dohme Sulphonamido-substituted bridged bicycloalkyl derivatives
AU2001252562A1 (en) * 2000-04-28 2001-11-12 Toshiharu Suzuki Medicinal compositions for suppressing beta-amyloid production
GB0108591D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
GB0108592D0 (en) * 2001-04-05 2001-05-23 Merck Sharp & Dohme Therapeutic agents
ATE515495T1 (de) 2001-08-03 2011-07-15 Schering Corp Gamma sekretase inhibitoren
WO2003013527A1 (en) 2001-08-03 2003-02-20 Schering Corporation Sulfonamide derivatives as gamma secretase inhibitors
EA006225B1 (ru) * 2001-08-21 2005-10-27 Мерк Шарп Энд Домэ Лимитед Новые циклогексилсульфоны
NZ533603A (en) 2001-12-20 2007-02-23 Bristol Myers Squibb Co Alpha-(N-sulphonamido)acetamide derivatives as beta-amyloid inhibitors used for treating Alzheimer's Disease and Down's syndrome
WO2003055850A1 (en) 2001-12-27 2003-07-10 Daiichi Pharmaceutical Co., Ltd. β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
DE10201392A1 (de) 2002-01-16 2003-07-31 Bayer Ag Phenylsulfoxide und-sulfone
TW200302717A (en) 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
DE60328182D1 (de) 2002-05-01 2009-08-13 Merck Sharp & Dohme Heteroaryl substituierte spirocyclische sulfamide zur hemmung von gamma sekretase
GB0209997D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0209995D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
GB0209991D0 (en) 2002-05-01 2002-06-12 Merck Sharp & Dohme Therapeutic agents
RU2321394C2 (ru) 2002-06-11 2008-04-10 Уайт Замещенные фенилсульфонамидные ингибиторы продуцирования бета-амилоида
ES2315525T3 (es) 2002-08-23 2009-04-01 Eli Lilly And Company Derivados de 2-(feniltiometil)-morfolina para uso como inhibidores selectivos de la recaptacion de norepinefrina.
GB0223038D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223040D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0223039D0 (en) 2002-10-04 2002-11-13 Merck Sharp & Dohme Therapeutic compounds
GB0225475D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
GB0225474D0 (en) 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
KR20060066057A (ko) * 2003-06-30 2006-06-15 다이이찌 세이야꾸 가부시기가이샤 복소환 메틸 설폰 유도체
RU2404968C2 (ru) * 2005-04-08 2010-11-27 Дайити Санкио Компани, Лимитед Пиридилдиметилсульфоновое производное

Also Published As

Publication number Publication date
US20070293495A1 (en) 2007-12-20
KR20040068978A (ko) 2004-08-02
TW200306810A (en) 2003-12-01
US20050234109A1 (en) 2005-10-20
RU2304140C2 (ru) 2007-08-10
EP1466898A1 (en) 2004-10-13
JPWO2003055850A1 (ja) 2005-05-12
HK1071354A1 (zh) 2005-07-15
CA2471943A1 (en) 2003-07-10
AU2002367147A1 (en) 2003-07-15
WO2003055850A1 (en) 2003-07-10
KR100927304B1 (ko) 2009-11-18
CN100562516C (zh) 2009-11-25
US7399775B2 (en) 2008-07-15
CA2471943C (en) 2011-09-20
TWI330176B (en) 2010-09-11
JP4329905B2 (ja) 2009-09-09
EP1466898A4 (en) 2005-12-07
CN1585746A (zh) 2005-02-23

Similar Documents

Publication Publication Date Title
RU2004122915A (ru) Ингибиторы продуцирования / секреции b-амилоидного белка
MX2021000887A (es) Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
JP2003506354A5 (ru)
AU2014251087B2 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
MX2019013954A (es) Inhibidores covalentes de kras.
EA023500B1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
JP2019521988A5 (ru)
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
SV2002000748A (es) Formas de sal de amida de acido 3-(4-bromo-2,6-difluoro-benciloxi)-5-[3-(4-pirrolidin-1-ilbutil)ureido]isotiazol-4- carboxilico y metodo de produccion ref.pc11042/700023/bb
MX2023006770A (es) Metodos de tratamiento para fibrosis quistica.
MX2024009444A (es) Métodos de tratamiento para la fibrosis quística
MX9205466A (es) Procedimiento para la preparacion de un medicamento para la administracion oral o topica en el tratamiento de leishmaniasis
MX2025007797A (es) Derivado de tetrahidrotiofeno y uso de este en medicina
RU2013136861A (ru) Новое производное индола или индазола или его соль
ZA202501471B (en) Preparation and use of quinazolinone derivative as kinase inhibitor
AR078126A1 (es) Antagonistas de glicina b, composiciones farmaceuticas, usos y proceso de preparacion de los mismos
CA3155875A1 (en) BIARYL COMPOUND SUBSTITUTED BY SULFO OR CORRESPONDING SALT, METHOD FOR PREPARATION AND USE
ZA200300641B (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder.
BRPI0416882A (pt) composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
MX2023003783A (es) Formulaciones farmaceuticas para tratar enfermedades mediadas por kdm1a.
PE20231945A1 (es) Regimenes para el tratamiento de los trastornos de la perdida de cabello con inhibidores de jak deuterados
GEAP202516634A (en) Heteroaryl compounds for the treatment of pain

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20131228